278 related articles for article (PubMed ID: 32066040)
1. The effect of activated κ-opioid receptor (κ-OR) on the role of calcium sensing receptor (CaSR) in preventing hypoxic pulmonary hypertension development.
Li J; Jia M; Liu M; Cao Z; Wang X; Feng N; Gu X; Zhang S; Fan R; Guo H; Wang Y; Liu M; Pei J
Biomed Pharmacother; 2020 May; 125():109931. PubMed ID: 32066040
[TBL] [Abstract][Full Text] [Related]
2. The Protective Effects of Κ-Opioid Receptor Stimulation in Hypoxic Pulmonary Hypertension Involve Inhibition of Autophagy Through the AMPK-MTOR Pathway.
Zhou Y; Wang Y; Wang X; Tian X; Zhang S; Yang F; Guo H; Fan R; Feng N; Jia M; Gu X; Wang Y; Li J; Pei J
Cell Physiol Biochem; 2017; 44(5):1965-1979. PubMed ID: 29224002
[TBL] [Abstract][Full Text] [Related]
3. Quaternary ammonium salt of U50,488H elicits protective effects against hypoxic pulmonary hypertension.
Zhou Y; Tian X; Wang X; Wang Y; Fan R; Wang Y; Feng N; Zhang S; Guo H; Gu X; Jia M; Yin W; Hou Z; Li J; Pei J
Eur J Pharmacol; 2018 Aug; 832():129-137. PubMed ID: 29782857
[TBL] [Abstract][Full Text] [Related]
4. Effects of U50,488H on hypoxia pulmonary hypertension and its underlying mechanism.
Li J; Zhang P; Zhang QY; Zhang SM; Guo HT; Bi H; Wang YM; Sun X; Liu JC; Cheng L; Cui Q; Yu SQ; Kaye AD; Yi DH; Pei JM
Vascul Pharmacol; 2009; 51(2-3):72-7. PubMed ID: 19351568
[TBL] [Abstract][Full Text] [Related]
5. Role of κ-opioid receptor in hypoxic pulmonary artery hypertension and its underlying mechanism.
Zhang L; Li J; Shi Q; Fan R; Kaye AJ; Wang Y; Sun X; Rivera FB; Kaye AD; Pei J
Am J Ther; 2013; 20(4):329-36. PubMed ID: 23838631
[TBL] [Abstract][Full Text] [Related]
6. Role of dynorphin in hypoxic pulmonary hypertension.
Li J; Liang X; Zhou Y; Zhang S; Yang F; Guo H; Fan R; Feng N; Jia M; Wang Y; Liu M; Pei J
Eur J Pharmacol; 2016 Nov; 791():78-84. PubMed ID: 27568355
[TBL] [Abstract][Full Text] [Related]
7. Κ-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension.
Wu Q; Wang HY; Li J; Zhou P; Wang QL; Zhao L; Fan R; Wang YM; Xu XZ; Yi DH; Yu SQ; Pei JM
PLoS One; 2013; 8(5):e60850. PubMed ID: 23667430
[TBL] [Abstract][Full Text] [Related]
8. U50,488H depresses pulmonary pressure in rats subjected to chronic hypoxia.
Pei JM; Sun X; Guo HT; Ma S; Zang YM; Lu SY; Bi H; Wang YM; Ma H; Ma XL
J Cardiovasc Pharmacol; 2006 Apr; 47(4):594-8. PubMed ID: 16680074
[TBL] [Abstract][Full Text] [Related]
9. Vasculoprotective effect of U50,488H in rats exposed to chronic hypoxia: role of Akt-stimulated NO production.
Li J; Shi QX; Fan R; Zhang LJ; Zhang SM; Guo HT; Wang YM; Kaye AJ; Kaye AD; Bueno FR; Xu XZ; Yu SQ; Yi DH; Pei JM
J Appl Physiol (1985); 2013 Jan; 114(2):238-44. PubMed ID: 23139366
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
Yamamura A; Guo Q; Yamamura H; Zimnicka AM; Pohl NM; Smith KA; Fernandez RA; Zeifman A; Makino A; Dong H; Yuan JX
Circ Res; 2012 Aug; 111(4):469-81. PubMed ID: 22730443
[TBL] [Abstract][Full Text] [Related]
11. Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.
Guo M; Zhang M; Cao X; Fang X; Li K; Qin L; He Y; Zhao J; Xu Y; Liu X; Li X
Respir Res; 2022 Jan; 23(1):6. PubMed ID: 35016680
[TBL] [Abstract][Full Text] [Related]
12. Notch activation of Ca
Guo Q; Xu H; Yang X; Zhao D; Liu S; Sun X; Huang JA
Hypertens Res; 2017 Feb; 40(2):117-129. PubMed ID: 27581537
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived growth factor up-regulates Ca
Yamamura A; Nayeem MJ; Al Mamun A; Takahashi R; Hayashi H; Sato M
FASEB J; 2019 Jun; 33(6):7363-7374. PubMed ID: 30865840
[TBL] [Abstract][Full Text] [Related]
14. Involvement of calcium-sensing receptors in hypoxia-induced vascular remodeling and pulmonary hypertension by promoting phenotypic modulation of small pulmonary arteries.
Peng X; Li HX; Shao HJ; Li GW; Sun J; Xi YH; Li HZ; Wang XY; Wang LN; Bai SZ; Zhang WH; Zhang L; Yang GD; Wu LY; Wang R; Xu CQ
Mol Cell Biochem; 2014 Nov; 396(1-2):87-98. PubMed ID: 25063217
[TBL] [Abstract][Full Text] [Related]
15. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
Yu XC; Wang HX; Pei JM; Wong TM
J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
[TBL] [Abstract][Full Text] [Related]
16. Vasorelaxing effect of U50,488H in pulmonary artery and underlying mechanism in rats.
Sun X; Ma S; Zang YM; Lu SY; Guo HT; Bi H; Wang YM; Ma H; Ma XL; Pei JM
Life Sci; 2006 Apr; 78(21):2516-22. PubMed ID: 16336977
[TBL] [Abstract][Full Text] [Related]
17. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors.
Yu XC; Li HY; Wang HX; Wong TM
J Mol Cell Cardiol; 1998 Feb; 30(2):405-13. PubMed ID: 9515017
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.
Cheng L; Ma S; Wei LX; Guo HT; Huang LY; Bi H; Fan R; Li J; Liu YL; Wang YM; Sun X; Zhang QY; Yu SQ; Yi DH; Ma XL; Pei JM
Heart Vessels; 2007 Sep; 22(5):335-44. PubMed ID: 17879026
[TBL] [Abstract][Full Text] [Related]
19. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY
J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034
[TBL] [Abstract][Full Text] [Related]
20. Activation of κ-opioid receptor by U50,488H improves vascular dysfunction in streptozotocin-induced diabetic rats.
Zhou X; Wang D; Zhang Y; Zhang J; Xiang D; Wang H
BMC Endocr Disord; 2015 Feb; 15():7. PubMed ID: 25887435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
